Tryp Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
For the nine months, net loss was CAD 3.58 million compared to CAD 5.33 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | 0.00% | +50.00% |
1st Jan change | Capi. | |
---|---|---|
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |